Cargando…

Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy

Insulin-like growth factor like family member 2 (IGFL2) is a gene in the IGFL family, located on chromosome 19, whose role in cancer is unclear, and the aim of this study was to investigate the relevance of IGFL2 expression, prognosis, immunity, and mutation in pan-cancer. Obtaining information from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yuqi, Yuan, Hongwei, Yue, Genquan, Zhao, Lingyan, Xia, Yuan, Zhang, Nan, Li, Hailing, Liu, Dongyang, Su, Yubo, Wang, Haisheng, Gao, Yumin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101991/ https://www.ncbi.nlm.nih.gov/pubmed/37055418 http://dx.doi.org/10.1038/s41598-023-27602-7

Ejemplares similares

LncRNA IGFL2-AS1 Promotes the Proliferation, Migration, and Invasion of Colon Cancer Cells and is Associated with Patient Prognosis
por: Cen, Xiaoning, et al.
Publicado: (2021)

IGFL2-AS1, a Long Non-Coding RNA, Is Associated with Radioresistance in Colorectal Cancer
por: Lee, Jeeyong, et al.
Publicado: (2023)

Role of ARRB1 in prognosis and immunotherapy: A Pan-Cancer analysis
por: Ye, Yingquan, et al.
Publicado: (2022)

Murine Insulin Growth Factor-like (IGFL) and Human IGFL1 Proteins Are Induced in Inflammatory Skin Conditions and Bind to a Novel Tumor Necrosis Factor Receptor Family Member, IGFLR1
por: Lobito, Adrian A., et al.
Publicado: (2011)

Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy
por: Zhao, Qinfei, et al.
Publicado: (2022)

The Pan-Cancer Crosstalk Between the EFNA Family and Tumor Microenvironment for Prognosis and Immunotherapy of Gastric Cancer
por: Xie, Rongrong, et al.
Publicado: (2022)

Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy
por: Liu, Jinhui, et al.
Publicado: (2022)

Pan-cancer analyses of pyroptosis with functional implications for prognosis and immunotherapy in cancer
por: Liu, Aibin, et al.
Publicado: (2022)

Roles of HMGBs in Prognosis and Immunotherapy: A Pan-Cancer Analysis
por: Lin, Tong, et al.
Publicado: (2021)

IGFL2‐AS1‐induced suppression of HIF‐1α degradation promotes cell proliferation and invasion in colorectal cancer by upregulating CA9
por: Qin, Mengdi, et al.
Publicado: (2022)

Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy
por: Zhao, Xiashuang, et al.
Publicado: (2023)

Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response
por: Zheng, Hong, et al.
Publicado: (2023)

Systematic analysis reveals a pan-cancer SNHG family signature predicting prognosis and immunotherapy response
por: Zheng, Haotian, et al.
Publicado: (2023)

Comprehensive Pan-Cancer Analyses of Immunogenic Cell Death as a Biomarker in Predicting Prognosis and Therapeutic Response
por: Wang, Yuan, et al.
Publicado: (2022)

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021)

A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer
por: Zhuang, Lingling, et al.
Publicado: (2023)

Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers
por: Cai, Yuan, et al.
Publicado: (2022)

Pan-Cancer Analysis of the Characteristics of LY96 in Prognosis and Immunotherapy Across Human Cancer
por: Nie, Kechao, et al.
Publicado: (2022)

Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
por: Tu, Zewei, et al.
Publicado: (2023)

Extracellular Vesicle-Mediated Transfer of LncRNA IGFL2-AS1 Confers Sunitinib Resistance in Renal Cell Carcinoma
por: Pan, Yihui, et al.
Publicado: (2023)

Systematic analysis of the necroptosis index in pan-cancer and classification in discriminating the prognosis and immunotherapy responses of 1716 glioma patients
por: Ma, Shuai, et al.
Publicado: (2023)

Pan-Cancer Analysis Predicts FOXS1 as a Key Target in Prognosis and Tumor Immunotherapy
por: Liu, Yunqiang, et al.
Publicado: (2022)

Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy
por: Zhang, Jing, et al.
Publicado: (2022)

Pan-cancer analysis of Homeobox B9 as a predictor for prognosis and immunotherapy in human tumors
por: Jin, Qingdong, et al.
Publicado: (2023)

A tumor-associated endothelial signature score model in immunotherapy and prognosis across pan-cancers
por: Chen, Shuzhao, et al.
Publicado: (2023)

Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker
por: Tang, Yumei, et al.
Publicado: (2023)

Pan-cancer analysis of NLRP3 inflammasome with potential implications in prognosis and immunotherapy in human cancer
por: Ju, Mingyi, et al.
Publicado: (2020)

Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy
por: Cui, Zhiwei, et al.
Publicado: (2023)

Pan-Cancer Analysis and Experimental Validation of SOX4 as a Potential Diagnosis, Prognosis, and Immunotherapy Biomarker
por: Deng, Xinna, et al.
Publicado: (2023)

GIMAP7 as a Potential Predictive Marker for Pan-Cancer Prognosis and Immunotherapy Efficacy
por: Qin, Yan, et al.
Publicado: (2022)

Pan-cancer analysis of ADAMs: A promising biomarker for prognosis and response to chemotherapy and immunotherapy
por: Ma, Bo, et al.
Publicado: (2023)

Sperm Autoantigenic Protein 17 Predicts the Prognosis and the Immunotherapy Response of Cancers: A Pan-Cancer Analysis
por: Tu, Zewei, et al.
Publicado: (2022)

The Pan-Cancer Landscape of Crosstalk Between TRP Family and Tumour Microenvironment Relevant to Prognosis and Immunotherapy Response
por: Wu, Gujie, et al.
Publicado: (2022)

The role of Angiogenesis and remodeling (AR) associated signature for predicting prognosis and clinical outcome of immunotherapy in pan-cancer
por: Sun, Xiaojiao, et al.
Publicado: (2022)

Comprehensive pan-cancer analysis of N7-methylguanosine regulators: Expression features and potential implications in prognosis and immunotherapy
por: Wei, Wei, et al.
Publicado: (2022)

Identification of OTUD6B as a new biomarker for prognosis and immunotherapy by pan-cancer analysis
por: Zhao, Guang, et al.
Publicado: (2022)

Pan-cancer analysis identifies the correlations of Thymosin Beta 10 with predicting prognosis and immunotherapy response
por: Li, Zhanzhan, et al.
Publicado: (2023)

Comprehensive analysis of PILRΑ’s association with the prognosis, tumor immune infiltration, and immunotherapy in pan-cancer
por: Li, Qiao, et al.
Publicado: (2023)

DEF6 has potential to be a biomarker for cancer prognosis: A pan-cancer analysis
por: Yuan, Ziming, et al.
Publicado: (2023)

An association between ATP7B expression and human cancer prognosis and immunotherapy: a pan-cancer perspective
por: Zhang, Zhanzhan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_knp2nhd1pkfu2dq0hfrqe25ng0